Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Rheumatic Diseases|November 15, 2025
The Impact of Early Belimumab Use on Successful Glucocorticoid Tapering to a Low Maintenance Dose in Treatment-naïve, Newly Diagnosed Systemic Lupus ErythematosusTakehiro Nakai, Sho Fukui, Yukihiko Ikeda, et al.
International Journal of Rheumatic Diseases|June 8, 2018
Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospitalMasei Suda, Yasuhiro Suyama, Sachiko Ohde, et al.
Sensors (Basel, Switzerland)|November 27, 2024
Noninvasive Early Detection of Systemic Inflammatory Response Syndrome of COVID-19 Inpatients Using a Piezoelectric Respiratory Rates SensorTsuyoshi Kobayashi, Takemi Matsui, Isamu Sugita, et al.
Best Practice & Research. Clinical Rheumatology|May 29, 2023
Current evidence and practical knowledge for ultrasound-guided procedures in rheumatology: Joint aspiration, injection, and other applicationsSho Fukui, Ryo Rokutanda, Satoshi Kawaai, et al.
Rheumatology (Oxford, England)|March 16, 2021
Effectiveness and safety of mizoribine for the treatment of IgG4-related disease: a retrospective cohort studySho Fukui, Satoshi Kawaai, Takehiro Nakai, et al.
Medicine|October 1, 2022
Advantages of an alternate-day glucocorticoid treatment strategy for the treatment of IgG4-related disease: A preliminary retrospective cohort studySho Fukui, Takehiro Nakai, Satoshi Kawaai, et al.
International Journal of Rheumatic Diseases|April 13, 2021
Performance of a pre-administration infection screening questionnaire in patients with rheumatoid arthritis administered biological disease-modifying antirheumatic drugsSho Fukui, Masei Suda, Sayaka Furukawa, et al.
Modern Rheumatology Case Reports|August 27, 2022
A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with reviewTakehiro Nakai, Yukihiko Ikeda, Kenichi Yamaguchi, et al.
Rheumatology International|February 9, 2025
A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective studyTakanori Ito, Sho Fukui, Fumika N Nagase, et al.
International Journal of Rheumatic Diseases|December 19, 2025
Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese StudyNobuhiro Oda, Sho Fukui, Fumika N Nagase, et al.
Pageof 3